Livzon Pharmaceutical Group Inc
SZSE:000513
Livzon Pharmaceutical Group Inc
SZSE:000513
Price:
40.1 CNY
1.75%
Market Closed
Updated:
May 3, 2024
Livzon Pharmaceutical Group Inc
Net Income (Common)
|
Livzon Pharmaceutical Group Inc
Net Income (Common) Peer Comparison
Comparables:
H
3692
600436
600276
000538
C
300765
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Livzon Pharmaceutical Group Inc
SZSE:000513
|
Net Income (Common)
¥2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Net Income (Common)
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Net Income (Common)
¥2.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Net Income (Common)
¥4.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Net Income (Common)
¥4.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Net Income (Common)
¥755.6m
|
CAGR 3-Years
36%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
See Also
What is Livzon Pharmaceutical Group Inc's Net Income (Common)?
Net Income (Common)
2B
CNY
2B
CNY
Based on the financial report for Dec 31, 2023, Livzon Pharmaceutical Group Inc's Net Income (Common) amounts to 2B CNY.
What is Livzon Pharmaceutical Group Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
15%
15%
Over the last year, the Net Income (Common) growth was 2%. The average annual Net Income (Common) growth rates for Livzon Pharmaceutical Group Inc have been 4% over the past three years , 13% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
